e-learning
resources
Virtual 2020
Pre-Congress Content
Clinical and functional evaluation of asthmatics
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Distribution of ACO among the Obstructive Airway Diseases (OADs) - 9 month study.
R. Agrawal (Bareilly, India), R. Agarwal (Bareilly, India), S. Goel (Bareilly, India)
Source:
Virtual Congress 2020 – Clinical and functional evaluation of asthmatics
Session:
Clinical and functional evaluation of asthmatics
Session type:
E-poster session
Number:
2653
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Agrawal (Bareilly, India), R. Agarwal (Bareilly, India), S. Goel (Bareilly, India). Distribution of ACO among the Obstructive Airway Diseases (OADs) - 9 month study.. 2653
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Late Breaking Abstract - Inhaled corticosteroids (ICS), blood eosinophils (EOS), and FEV1 decline in patients with Chronic Obstructive Pulmonary Disease in a large UK primary healthcare setting
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018
The prevalence of Chronic Obstructive Pulmonary Disease (COPD) in 1995-97 and 2006-08: The HUNT study, Norway.
Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function
Year: 2017
(in)Appropriate LAMA Prescribing in Asthma patients: a Cohort Analysis (the ALPACA study)
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020
Oral Appliances (OAs) treatment in Obstructive Sleep Apnea (OSA) : a three years experience
Source: International Congress 2018 – Treatments that can serve as an alternative to positive airway pressure (PAP)
Year: 2018
As-needed formoterol (F) in asthma: An analysis of the East-Asian subgroup of the RELIEF study
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
Romanian awareness and screenings for Obstructive Airway disease - World Asthma and COPD Day 2017
Source: International Congress 2018 – Airway disease: recent discoveries
Year: 2018
Long-term (5 year) safety of bronchial thermoplasty in patients with moderate to severe asthma: Asthma Intervention Research (AIR) Trial
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010
COPD prevalence in Portugal. The Burden of Obstructive Lung Disease study (BOLD)
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010
Metabolic Syndrome (MetS) as a comorbidity of Chronic Obstructive Pulmonary Disease (COPD)
Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases
Year: 2021
Physical activity and symptom burden in COPD: The Canadian Cohort Obstructive Lung Disease (CanCOLD) study
Source: Virtual Congress 2021 – Lung disease burden and management
Year: 2021
Obstructive sleep apnea accelerates decline in FEV1 in asthmatic patients
Source: International Congress 2014 – Direct and indirect monitoring of comorbidities
Year: 2014
A service evaluation of the accuracy of the Gold Standard Framework Proactive Indicator Guidance (GSF PIG) in predicting 12 month mortality in patietns with a diagnosis of Chronic Obstructive Pulmonary Disease (COPD).
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Distance estimation and functional distance perception in patients with Chronic Obstructive Lung Disease (COPD).
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021
Unemployment in chronic airflow obstruction (CAO) around the world: Results from the Burden of Obstructive Lung Disease (BOLD) study
Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function
Year: 2017
One year change in health status in patients with stable Chronic Obstructive Pulmonary Disease (COPD) under long-acting bronchodilators treatment
Source: International Congress 2017 – Bronchodilators and bronchoprotectors
Year: 2017
The ALONNISOS STUDY: Cross-sectional study of the prevalence of Obstructive Sleep Apnea Syndrome (OSAS) and Chronic Obstructive Pulmonary Disease (COPD) in the general population of Alonissos.
Source: Virtual Congress 2020 – Phenotyping sleep-disordered breathing and its impact on various diseases
Year: 2020
Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) - is it a separate entity?
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
Correlations between Lung Clearance Index (LCI) measurements and spirometry in Chronic Obstructive Pulmonary Disease (COPD).
Source: International Congress 2019 – Role of the physiotherapist for patients with lung disease
Year: 2019
Compliance of Continuous Positive Airway Pressure (CPAP) therapy in patients with Obstructive Sleep ApnoeaSyndrome (OSAS) in Sri Lanka
Source: Sleep and Breathing Conference 2021
Year: 2021
Evaluation of the use of CAT in COPD. Results of On-Sint study
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept